570 Blockade of the inhibitory collagen receptor LAIR-1, PD-L1, and TGF-β promotes anti-tumor activity through T cell activation and myeloid cell polarization
Lucas A. Horn(National Institutes of Health), Claudia Palena(National Cancer Institute), Masafumi Iida(Tohoku University), Dallas B. Flies(Mayo Clinic in Arizona), Jeffrey Schlom(National Cancer Institute), Zachary Cusumano, Kristen Fousek(National Cancer Institute), Han Myint, Solomon Langermann(Altimmune (United States)), Ronald J. Copeland(Johns Hopkins University), Haiyan Qin(National Cancer Institute)
Cited by 0
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
|The Journal of Experimental Medicine|2006|1.7k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|973
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
|Blood|2005|896
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
|Immunity|2003|694